Global Human Papillomavirus (HPV) Testing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 138 pages | ID: GFCDC065C4DEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
HPV infections can infect the genital areas of men including the skin on and around the penis or anus. These infections can also be spread to the mouth and the throat. Even when HPV infections are persistent to the male population and can cause severe diseases such as genital warts, anal cancers, penile cancers, and cancers of the oropharynx, there is currently no HPV test recommend for men. The approved tests available in the market are for screening women for cervical cancers. They are not useful for the screening of HPV-related cancers or genital warts in men.

Scope of the Report:

The global Human Papillomavirus (HPV) Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Human Papillomavirus (HPV) Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Human Papillomavirus (HPV) Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Human Papillomavirus (HPV) Testing market by product type and applications/end industries.

Market Segment by Companies, this report covers
  • Roche
  • Agilent Technologies 
  • Becton, Dickinson and Company 
  • Qiagen N.V. 
  • Thermo Fisher Scientific Inc. 
  • Abbott Laboratories 
  • Hologic Inc. 
  • Cepheid Inc. 
  • Seegene Inc. 
  • Takara Bio Inc. 
  • DaAn Gene of Sun Yat-Sen University 
  • Promega Corporation 
  • Greiner Bio-One International GmbH (Greiner Holding AG) 
  • Enzo Biochem Inc. 
  • Norgen Biotek 
  • DiagCor Bioscience Inc Ltd 
  • Hybribio Limited 
  • Zytovision GmbH 
  • Arbor Vita Corporation 
  • Medical & Biological Laboratories Co., Ltd 
  • Fujirebio Diagnostics
Market Segment by Regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • Pap Smear Test
  • HPV DNA Test
Market Segment by Applications, can be divided into
  • Diagnostic Centers
  • Hospitals
  • Clinic
1 HUMAN PAPILLOMAVIRUS (HPV) TESTING MARKET OVERVIEW

1.1 Product Overview and Scope of Human Papillomavirus (HPV) Testing
1.2 Classification of Human Papillomavirus (HPV) Testing by Types
  1.2.1 Global Human Papillomavirus (HPV) Testing Revenue Comparison by Types (2017-2023)
  1.2.2 Global Human Papillomavirus (HPV) Testing Revenue Market Share by Types in 2017
  1.2.3 Pap Smear Test
  1.2.4 HPV DNA Test
1.3 Global Human Papillomavirus (HPV) Testing Market by Application
  1.3.1 Global Human Papillomavirus (HPV) Testing Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Diagnostic Centers
  1.3.3 Hospitals
  1.3.4 Clinic
1.4 Global Human Papillomavirus (HPV) Testing Market by Regions
  1.4.1 Global Human Papillomavirus (HPV) Testing Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Human Papillomavirus (HPV) Testing Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Human Papillomavirus (HPV) Testing Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Papillomavirus (HPV) Testing Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Human Papillomavirus (HPV) Testing Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Papillomavirus (HPV) Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Human Papillomavirus (HPV) Testing (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Roche
  2.1.1 Business Overview
  2.1.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Roche Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Agilent Technologies
  2.2.1 Business Overview
  2.2.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Agilent Technologies Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Becton, Dickinson and Company
  2.3.1 Business Overview
  2.3.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Becton, Dickinson and Company Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Qiagen N.V.
  2.4.1 Business Overview
  2.4.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Qiagen N.V. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Thermo Fisher Scientific Inc.
  2.5.1 Business Overview
  2.5.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Thermo Fisher Scientific Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abbott Laboratories
  2.6.1 Business Overview
  2.6.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Abbott Laboratories Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hologic Inc.
  2.7.1 Business Overview
  2.7.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Hologic Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cepheid Inc.
  2.8.1 Business Overview
  2.8.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Cepheid Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Seegene Inc.
  2.9.1 Business Overview
  2.9.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Seegene Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Takara Bio Inc.
  2.10.1 Business Overview
  2.10.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Takara Bio Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.11 DaAn Gene of Sun Yat-Sen University
  2.11.1 Business Overview
  2.11.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 DaAn Gene of Sun Yat-Sen University Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.12 Promega Corporation
  2.12.1 Business Overview
  2.12.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 Promega Corporation Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.13 Greiner Bio-One International GmbH (Greiner Holding AG)
  2.13.1 Business Overview
  2.13.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.13.2.1 Product A
    2.13.2.2 Product B
  2.13.3 Greiner Bio-One International GmbH (Greiner Holding AG) Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.14 Enzo Biochem Inc.
  2.14.1 Business Overview
  2.14.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.14.2.1 Product A
    2.14.2.2 Product B
  2.14.3 Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.15 Norgen Biotek
  2.15.1 Business Overview
  2.15.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.15.2.1 Product A
    2.15.2.2 Product B
  2.15.3 Norgen Biotek Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.16 DiagCor Bioscience Inc Ltd
  2.16.1 Business Overview
  2.16.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.16.2.1 Product A
    2.16.2.2 Product B
  2.16.3 DiagCor Bioscience Inc Ltd Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.17 Hybribio Limited
  2.17.1 Business Overview
  2.17.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.17.2.1 Product A
    2.17.2.2 Product B
  2.17.3 Hybribio Limited Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.18 Zytovision GmbH
  2.18.1 Business Overview
  2.18.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.18.2.1 Product A
    2.18.2.2 Product B
  2.18.3 Zytovision GmbH Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.19 Arbor Vita Corporation
  2.19.1 Business Overview
  2.19.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.19.2.1 Product A
    2.19.2.2 Product B
  2.19.3 Arbor Vita Corporation Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.20 Medical & Biological Laboratories Co., Ltd
  2.20.1 Business Overview
  2.20.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.20.2.1 Product A
    2.20.2.2 Product B
  2.20.3 Medical & Biological Laboratories Co., Ltd Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.21 Fujirebio Diagnostics
  2.21.1 Business Overview
  2.2.2 Human Papillomavirus (HPV) Testing Type and Applications
    2.21.2.1 Product A
    2.21.2.2 Product B
  2.21.3 Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL HUMAN PAPILLOMAVIRUS (HPV) TESTING MARKET COMPETITION, BY PLAYERS

3.1 Global Human Papillomavirus (HPV) Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Human Papillomavirus (HPV) Testing Players Market Share
  3.2.2 Top 10 Human Papillomavirus (HPV) Testing Players Market Share
3.3 Market Competition Trend

4 GLOBAL HUMAN PAPILLOMAVIRUS (HPV) TESTING MARKET SIZE BY REGIONS

4.1 Global Human Papillomavirus (HPV) Testing Revenue and Market Share by Regions
4.2 North America Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
4.5 South America Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA HUMAN PAPILLOMAVIRUS (HPV) TESTING REVENUE BY COUNTRIES

5.1 North America Human Papillomavirus (HPV) Testing Revenue by Countries (2013-2018)
5.2 USA Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)

6 EUROPE HUMAN PAPILLOMAVIRUS (HPV) TESTING REVENUE BY COUNTRIES

6.1 Europe Human Papillomavirus (HPV) Testing Revenue by Countries (2013-2018)
6.2 Germany Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
6.3 UK Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
6.4 France Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC HUMAN PAPILLOMAVIRUS (HPV) TESTING REVENUE BY COUNTRIES

7.1 Asia-Pacific Human Papillomavirus (HPV) Testing Revenue by Countries (2013-2018)
7.2 China Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
7.5 India Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA HUMAN PAPILLOMAVIRUS (HPV) TESTING REVENUE BY COUNTRIES

8.1 South America Human Papillomavirus (HPV) Testing Revenue by Countries (2013-2018)
8.2 Brazil Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE HUMAN PAPILLOMAVIRUS (HPV) TESTING BY COUNTRIES

9.1 Middle East and Africa Human Papillomavirus (HPV) Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)

10 GLOBAL HUMAN PAPILLOMAVIRUS (HPV) TESTING MARKET SEGMENT BY TYPE

10.1 Global Human Papillomavirus (HPV) Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Human Papillomavirus (HPV) Testing Market Forecast by Type (2018-2023)
10.3 Pap Smear Test Revenue Growth Rate (2013-2023)
10.4 HPV DNA Test Revenue Growth Rate (2013-2023)

11 GLOBAL HUMAN PAPILLOMAVIRUS (HPV) TESTING MARKET SEGMENT BY APPLICATION

11.1 Global Human Papillomavirus (HPV) Testing Revenue Market Share by Application (2013-2018)
11.2 Human Papillomavirus (HPV) Testing Market Forecast by Application (2018-2023)
11.3 Diagnostic Centers Revenue Growth (2013-2018)
11.4 Hospitals Revenue Growth (2013-2018)
11.5 Clinic Revenue Growth (2013-2018)

12 GLOBAL HUMAN PAPILLOMAVIRUS (HPV) TESTING MARKET SIZE FORECAST (2018-2023)

12.1 Global Human Papillomavirus (HPV) Testing Market Size Forecast (2018-2023)
12.2 Global Human Papillomavirus (HPV) Testing Market Forecast by Regions (2018-2023)
12.3 North America Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)
12.4 Europe Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)
12.6 South America Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES

Figure Human Papillomavirus (HPV) Testing Picture
Table Product Specifications of Human Papillomavirus (HPV) Testing
Table Global Human Papillomavirus (HPV) Testing and Revenue (Million USD) Market Split by Product Type
Figure Global Human Papillomavirus (HPV) Testing Revenue Market Share by Types in 2017
Figure Pap Smear Test Picture
Figure HPV DNA Test Picture
Table Global Human Papillomavirus (HPV) Testing Revenue (Million USD) by Application (2013-2023)
Figure Human Papillomavirus (HPV) Testing Revenue Market Share by Applications in 2017
Figure Diagnostic Centers Picture
Figure Hospitals Picture
Figure Clinic Picture
Table Global Market Human Papillomavirus (HPV) Testing Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Human Papillomavirus (HPV) Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Human Papillomavirus (HPV) Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Human Papillomavirus (HPV) Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Human Papillomavirus (HPV) Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Human Papillomavirus (HPV) Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Human Papillomavirus (HPV) Testing Revenue (Million USD) and Growth Rate (2013-2023)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Human Papillomavirus (HPV) Testing Type and Applications
Table Roche Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table Agilent Technologies Human Papillomavirus (HPV) Testing Type and Applications
Table Agilent Technologies Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table Becton, Dickinson and Company Human Papillomavirus (HPV) Testing Type and Applications
Table Becton, Dickinson and Company Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Qiagen N.V. Basic Information, Manufacturing Base and Competitors
Table Qiagen N.V. Human Papillomavirus (HPV) Testing Type and Applications
Table Qiagen N.V. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific Inc. Human Papillomavirus (HPV) Testing Type and Applications
Table Thermo Fisher Scientific Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Human Papillomavirus (HPV) Testing Type and Applications
Table Abbott Laboratories Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Hologic Inc. Basic Information, Manufacturing Base and Competitors
Table Hologic Inc. Human Papillomavirus (HPV) Testing Type and Applications
Table Hologic Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Cepheid Inc. Basic Information, Manufacturing Base and Competitors
Table Cepheid Inc. Human Papillomavirus (HPV) Testing Type and Applications
Table Cepheid Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Seegene Inc. Basic Information, Manufacturing Base and Competitors
Table Seegene Inc. Human Papillomavirus (HPV) Testing Type and Applications
Table Seegene Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table Takara Bio Inc. Human Papillomavirus (HPV) Testing Type and Applications
Table Takara Bio Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table DaAn Gene of Sun Yat-Sen University Basic Information, Manufacturing Base and Competitors
Table DaAn Gene of Sun Yat-Sen University Human Papillomavirus (HPV) Testing Type and Applications
Table DaAn Gene of Sun Yat-Sen University Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Promega Corporation Basic Information, Manufacturing Base and Competitors
Table Promega Corporation Human Papillomavirus (HPV) Testing Type and Applications
Table Promega Corporation Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Greiner Bio-One International GmbH (Greiner Holding AG) Basic Information, Manufacturing Base and Competitors
Table Greiner Bio-One International GmbH (Greiner Holding AG) Human Papillomavirus (HPV) Testing Type and Applications
Table Greiner Bio-One International GmbH (Greiner Holding AG) Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Enzo Biochem Inc. Basic Information, Manufacturing Base and Competitors
Table Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Type and Applications
Table Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Norgen Biotek Basic Information, Manufacturing Base and Competitors
Table Norgen Biotek Human Papillomavirus (HPV) Testing Type and Applications
Table Norgen Biotek Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table DiagCor Bioscience Inc Ltd Basic Information, Manufacturing Base and Competitors
Table DiagCor Bioscience Inc Ltd Human Papillomavirus (HPV) Testing Type and Applications
Table DiagCor Bioscience Inc Ltd Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Hybribio Limited Basic Information, Manufacturing Base and Competitors
Table Hybribio Limited Human Papillomavirus (HPV) Testing Type and Applications
Table Hybribio Limited Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Zytovision GmbH Basic Information, Manufacturing Base and Competitors
Table Zytovision GmbH Human Papillomavirus (HPV) Testing Type and Applications
Table Zytovision GmbH Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Arbor Vita Corporation Basic Information, Manufacturing Base and Competitors
Table Arbor Vita Corporation Human Papillomavirus (HPV) Testing Type and Applications
Table Arbor Vita Corporation Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Medical & Biological Laboratories Co., Ltd Basic Information, Manufacturing Base and Competitors
Table Medical & Biological Laboratories Co., Ltd Human Papillomavirus (HPV) Testing Type and Applications
Table Medical & Biological Laboratories Co., Ltd Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Fujirebio Diagnostics Basic Information, Manufacturing Base and Competitors
Table Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Type and Applications
Table Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Global Human Papillomavirus (HPV) Testing Revenue (Million USD) by Players (2013-2018)
Table Global Human Papillomavirus (HPV) Testing Revenue Share by Players (2013-2018)
Figure Global Human Papillomavirus (HPV) Testing Revenue Share by Players in 2016
Figure Global Human Papillomavirus (HPV) Testing Revenue Share by Players in 2017
Figure Global Top 5 Players Human Papillomavirus (HPV) Testing Revenue Market Share in 2017
Figure Global Top 10 Players Human Papillomavirus (HPV) Testing Revenue Market Share in 2017
Figure Global Human Papillomavirus (HPV) Testing Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Human Papillomavirus (HPV) Testing Revenue (Million USD) by Regions (2013-2018)
Table Global Human Papillomavirus (HPV) Testing Revenue Market Share by Regions (2013-2018)
Figure Global Human Papillomavirus (HPV) Testing Revenue Market Share by Regions (2013-2018)
Figure Global Human Papillomavirus (HPV) Testing Revenue Market Share by Regions in 2017
Figure North America Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure Europe Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure South America Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Table North America Human Papillomavirus (HPV) Testing Revenue by Countries (2013-2018)
Table North America Human Papillomavirus (HPV) Testing Revenue Market Share by Countries (2013-2018)
Figure North America Human Papillomavirus (HPV) Testing Revenue Market Share by Countries (2013-2018)
Figure North America Human Papillomavirus (HPV) Testing Revenue Market Share by Countries in 2017
Figure USA Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure Canada Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure Mexico Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Table Europe Human Papillomavirus (HPV) Testing Revenue (Million USD) by Countries (2013-2018)
Figure Europe Human Papillomavirus (HPV) Testing Revenue Market Share by Countries (2013-2018)
Figure Europe Human Papillomavirus (HPV) Testing Revenue Market Share by Countries in 2017
Figure Germany Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure UK Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure France Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure Russia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure Italy Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Human Papillomavirus (HPV) Testing Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Human Papillomavirus (HPV) Testing Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Human Papillomavirus (HPV) Testing Revenue Market Share by Countries in 2017
Figure China Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure Japan Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure Korea Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure India Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Table South America Human Papillomavirus (HPV) Testing Revenue by Countries (2013-2018)
Table South America Human Papillomavirus (HPV) Testing Revenue Market Share by Countries (2013-2018)
Figure South America Human Papillomavirus (HPV) Testing Revenue Market Share by Countries (2013-2018)
Figure South America Human Papillomavirus (HPV) Testing Revenue Market Share by Countries in 2017
Figure Brazil Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure Argentina Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure Colombia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Human Papillomavirus (HPV) Testing Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Human Papillomavirus (HPV) Testing Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Papillomavirus (HPV) Testing Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Papillomavirus (HPV) Testing Revenue Market Share by Countries in 2017
Figure Saudi Arabia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure UAE Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure Egypt Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure Nigeria Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Figure South Africa Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
Table Global Human Papillomavirus (HPV) Testing Revenue (Million USD) by Type (2013-2018)
Table Global Human Papillomavirus (HPV) Testing Revenue Share by Type (2013-2018)
Figure Global Human Papillomavirus (HPV) Testing Revenue Share by Type (2013-2018)
Figure Global Human Papillomavirus (HPV) Testing Revenue Share by Type in 2017
Table Global Human Papillomavirus (HPV) Testing Revenue Forecast by Type (2018-2023)
Figure Global Human Papillomavirus (HPV) Testing Market Share Forecast by Type (2018-2023)
Figure Global Pap Smear Test Revenue Growth Rate (2013-2018)
Figure Global HPV DNA Test Revenue Growth Rate (2013-2018)
Table Global Human Papillomavirus (HPV) Testing Revenue by Application (2013-2018)
Table Global Human Papillomavirus (HPV) Testing Revenue Share by Application (2013-2018)
Figure Global Human Papillomavirus (HPV) Testing Revenue Share by Application (2013-2018)
Figure Global Human Papillomavirus (HPV) Testing Revenue Share by Application in 2017
Table Global Human Papillomavirus (HPV) Testing Revenue Forecast by Application (2018-2023)
Figure Global Human Papillomavirus (HPV) Testing Market Share Forecast by Application (2018-2023)
Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinic Revenue Growth Rate (2013-2018)
Figure Global Human Papillomavirus (HPV) Testing Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Human Papillomavirus (HPV) Testing Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Human Papillomavirus (HPV) Testing Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)
Figure Europe Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)
Figure South America Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)


More Publications